Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
694.76
+17.82 (2.63%)
At close: Nov 6, 2026, 4:00 PM EST
692.00
-2.76 (-0.40%)
After-hours: Nov 6, 2026, 7:41 PM EST

Thermo Fisher Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Revenue
12,13711,99411,00512,21511,12210,85410,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,702
Other Revenue
-----1--------------
Revenue
12,13711,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,702
Revenue Growth (YoY)
9.13%10.49%6.19%7.20%4.94%2.98%0.18%4.68%0.23%-1.37%-3.41%-4.93%-0.97%-2.58%-9.38%6.99%14.44%18.30%19.30%1.44%
Cost of Revenue
6,9977,0846,5617,1716,5296,4366,1186,5516,2616,1946,1256,4716,2446,4186,5296,8446,3756,3716,3545,456
Gross Profit
5,1404,9104,4445,0444,5934,4194,2464,8444,3374,3474,2204,4154,3304,2694,1814,6064,3024,5995,4645,246
Selling, General & Admin
2,3412,2972,1382,2372,0982,1202,0642,1782,0792,1752,1642,0962,0352,1392,1112,1792,2242,2522,2702,093
Research & Development
348364336356346352342374346339331327319345346391351365364392
Other Operating Expenses
--1-135---30---1-------3
Operating Expenses
2,6892,6612,4752,4582,4442,4722,4062,5822,4252,5142,4952,4242,3542,4842,4572,5702,5752,6172,6342,488
Operating Income
2,4512,2491,9692,5862,1491,9471,8402,2621,9121,8331,7251,9911,9761,7851,7242,0361,7271,9822,8302,758
Interest Expense
-417-401-354-365-347-404-303-317-356-354-363-390-359-327-304-269-173-145-135-168
Interest & Investment Income
25220723325823429720322727729527930924617814615068361811
Earnings From Equity Investments
-9-15-8-3222-1433-14-8423-1-17-16-25-30-72-51-19-
Currency Exchange Gain (Loss)
-7-772330310-2115-4-6-21-6-2523702013-115
Other Non Operating Income (Expenses)
613-15-32-37-19-812-2697-4926-21-26-11-54-13
EBT Excluding Unusual Items
2,2762,0461,8322,4382,0311,8261,7282,1961,8081,6951,6651,8841,8491,6211,5431,9311,5591,8302,6972,603
Merger & Restructuring Charges
-9-28-50-40-10-10-1141-45--36159-84-21-166-9-33-24-2-23
Gain (Loss) on Sale of Investments
-924-1-448-3114-4-11-1311--44-25-1317-14143
Gain (Loss) on Sale of Assets
-172--------------14----
Asset Writedown
---14-94----252----219----60----12
Legal Settlements
------------19---18-----
Other Unusual Items
-7-134-41-137-201-102-112-25-30-13-27-53-28-18623-1041643-33-749
Pretax Income
2,0791,9081,7262,1231,8281,7111,6061,9741,7291,6821,6131,7391,7481,4141,3381,7471,5291,8662,5211,862
Income Tax Expense
3521677015320792951509912828113353524617331198301203
Earnings From Continuing Operations
1,7271,7411,6561,9701,6211,6191,5111,8241,6301,5541,3321,6061,6951,3621,2921,5741,4981,6682,2201,659
Net Income to Company
1,7271,7411,6561,9701,6211,6191,5111,8241,6301,5541,3321,6061,6951,3621,2921,5741,4981,6682,2201,659
Minority Interest in Earnings
-6-5-5-6-5-2-46--6-42420-1-32-3-4-5-1
Net Income
1,7211,7361,6511,9641,6161,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,4951,6642,2151,658
Net Income to Common
1,7211,7361,6511,9641,6161,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,4951,6642,2151,658
Net Income Growth (YoY)
6.50%7.36%9.55%7.32%-0.86%4.46%13.48%12.27%-4.96%13.74%3.03%3.43%14.72%-18.21%-41.81%-4.95%-21.40%-8.97%-5.22%-33.63%
Shares Outstanding (Basic)
370371372376378378378382382382382387386386386391392392392394
Shares Outstanding (Diluted)
371371373377378378379383384383384388388388388393395394395398
Shares Change (YoY)
-1.85%-1.85%-1.58%-1.57%-1.56%-1.31%-1.30%-1.29%-1.03%-1.29%-1.03%-1.27%-1.77%-1.52%-1.77%-1.26%-0.50%-0.51%-0.50%-0.50%
EPS (Basic)
4.654.684.445.224.284.283.994.794.274.053.484.214.443.533.344.033.814.245.654.21
EPS (Diluted)
4.644.684.435.194.274.283.984.784.254.043.464.204.423.513.323.993.794.225.614.16
EPS Growth (YoY)
8.67%9.38%11.31%8.59%0.47%5.89%15.03%13.81%-3.85%15.10%4.22%5.38%16.62%-16.83%-40.82%-4.18%-20.88%-8.46%-4.59%-33.28%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Free Cash Flow
2,1131,6758162,9921,8351,1053612,8101,8941,6599043,3182,0821,2562712,9371,3901,0221,5621,626
Free Cash Flow Per Share
5.704.512.197.944.852.920.957.344.934.332.358.555.373.240.707.473.522.593.954.08
Dividend Per Share
0.4700.4700.4700.4300.4300.4300.4300.3900.3900.3900.3900.3500.3500.3500.3500.3000.3000.3000.3000.260
Dividend Growth (YoY)
9.30%9.30%9.30%10.26%10.26%10.26%10.26%11.43%11.43%11.43%11.43%16.67%16.67%16.67%16.67%15.38%15.38%15.38%15.38%18.18%
Gross Margin
42.35%40.94%40.38%41.29%41.30%40.71%40.97%42.51%40.92%41.24%40.79%40.56%40.95%39.95%39.04%40.23%40.29%41.92%46.23%49.02%
Operating Margin
20.19%18.75%17.89%21.17%19.32%17.94%17.75%19.85%18.04%17.39%16.68%18.29%18.69%16.70%16.10%17.78%16.18%18.07%23.95%25.77%
Profit Margin
14.18%14.47%15.00%16.08%14.53%14.90%14.54%16.06%15.38%14.69%12.84%14.97%16.22%12.73%12.04%13.76%14.00%15.17%18.74%15.49%
Free Cash Flow Margin
17.41%13.96%7.41%24.49%16.50%10.18%3.48%24.66%17.87%15.74%8.74%30.48%19.69%11.75%2.53%25.65%13.02%9.32%13.22%15.19%
EBITDA
3,2763,0682,7033,3142,8102,6332,5453,0042,6622,6132,5612,8302,8292,6402,5832,8842,5652,8183,6893,441
EBITDA Margin
26.99%25.58%24.56%27.13%25.26%24.26%24.56%26.36%25.12%24.79%24.76%26.00%26.75%24.70%24.12%25.19%24.02%25.69%31.21%32.15%
D&A For EBITDA
825819734728661686705742750780836839853855859848838836859683
EBIT
2,4512,2491,9692,5862,1491,9471,8402,2621,9121,8331,7251,9911,9761,7851,7242,0361,7271,9822,8302,758
EBIT Margin
20.19%18.75%17.89%21.17%19.32%17.94%17.75%19.85%18.04%17.39%16.68%18.29%18.69%16.70%16.10%17.78%16.18%18.07%23.95%25.77%
Effective Tax Rate
16.93%8.75%4.06%7.21%11.32%5.38%5.92%7.60%5.73%7.61%17.42%7.65%3.03%3.68%3.44%9.90%2.03%10.61%11.94%10.90%
Revenue as Reported
12,13711,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,702
SEC Filings: 10-K · 10-Q